Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Brian D Kavanagh

TitleProfessor
InstitutionUniversity of Colorado Denver - Anschutz Medical Campus
DepartmentSOM-Radiation Oncology
Phone720/848-0295
    Other Positions
    TitleChair
    InstitutionUniversity of Colorado Denver - Anschutz Medical Campus
    DepartmentSOM-Radiation Oncology


    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Altunbas C, Kavanagh B, Alexeev T, Miften M. Transmission characteristics of a two dimensional antiscatter grid prototype for CBCT. Med Phys. 2017 May 17. PMID: 28513847.
      View in: PubMed
    2. Rusthoven CG, Palma DA, Senan S, Kavanagh BD. The Head Start Effect: Will Acute and Delayed Postoperative Mortality Lead to Improved Survival with Stereotactic Body Radiation Therapy for Operable Stage I Non-Small-Cell Lung Cancer? J Clin Oncol. 2017 May 20; 35(15):1749-1751. PMID: 28221860.
      View in: PubMed
    3. Goodman KA, Kavanagh BD. Stereotactic Body Radiotherapy for Liver Metastases. Semin Radiat Oncol. 2017 Jul; 27(3):240-246. PMID: 28577831.
      View in: PubMed
    4. Jackson MW, Palma DA, Camidge DR, Jones BL, Robin TP, Sher DJ, Koshy M, Kavanagh BD, Gaspar LE, Rusthoven CG. The Impact of Postoperative Radiotherapy for Thymoma and Thymic Carcinoma. J Thorac Oncol. 2017 Apr; 12(4):734-744. PMID: 28126540.
      View in: PubMed
    5. Magnuson WJ, Lester-Coll NH, Wu AJ, Yang TJ, Lockney NA, Gerber NK, Beal K, Amini A, Patil T, Kavanagh BD, Camidge DR, Braunstein SE, Boreta LC, Balasubramanian SK, Ahluwalia MS, Rana NG, Attia A, Gettinger SN, Contessa JN, Yu JB, Chiang VL. Management of Brain Metastases in Tyrosine Kinase Inhibitor-Naïve Epidermal Growth Factor Receptor-Mutant Non-Small-Cell Lung Cancer: A Retrospective Multi-Institutional Analysis. J Clin Oncol. 2017 Apr 01; 35(10):1070-1077. PMID: 28113019.
      View in: PubMed
    6. Vinogradskiy Y, Jackson M, Schubert L, Jones B, Castillo R, Castillo E, Guerrero T, Mitchell J, Rusthoven C, Miften M, Kavanagh B. Assessing the use of 4DCT-ventilation in pre-operative surgical lung cancer evaluation. Med Phys. 2017 Jan; 44(1):200-208. PMID: 28102961.
      View in: PubMed
    7. Rusthoven CG, Jones BL, Kavanagh BD, Pugh TJ. Reply to J.B. Aragon-Ching and D. Dalela et al. J Clin Oncol. 2017 Mar 10; 35(8):916-917. PMID: 27937090.
      View in: PubMed
    8. Gomez DR, Blumenschein GR, Lee JJ, Hernandez M, Ye R, Camidge DR, Doebele RC, Skoulidis F, Gaspar LE, Gibbons DL, Karam JA, Kavanagh BD, Tang C, Komaki R, Louie AV, Palma DA, Tsao AS, Sepesi B, William WN, Zhang J, Shi Q, Wang XS, Swisher SG, Heymach JV. Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study. Lancet Oncol. 2016 Dec; 17(12):1672-1682. PMID: 27789196.
      View in: PubMed
    9. Vinogradskiy Y, Schubert L, Diot Q, Waxweiller T, Koo P, Castillo R, Castillo E, Guerrero T, Rusthoven C, Gaspar L, Kavanagh B, Miften M. Regional Lung Function Profiles of Stage I and III Lung Cancer Patients: An Evaluation for Functional Avoidance Radiation Therapy. Int J Radiat Oncol Biol Phys. 2016 Jul 15; 95(4):1273-80. PMID: 27354134; PMCID: PMC4929409 [Available on 07/15/17].
    10. Kavanagh BD. From the Guest Editor: New Lenses, New Visions for Radiotherapy in the Molecular-Genetic-Immunomodulator Era of Oncology. Cancer J. 2016 Jul-Aug; 22(4):245-6. PMID: 27441743.
      View in: PubMed
    11. Benedict SH, Hoffman K, Martel MK, Abernethy AP, Asher AL, Capala J, Chen RC, Chera B, Couch J, Deye J, Efstathiou JA, Ford E, Fraass BA, Gabriel PE, Huser V, Kavanagh BD, Khuntia D, Marks LB, Mayo C, McNutt T, Miller RS, Moore KL, Prior F, Roelofs E, Rosenstein BS, Sloan J, Theriault A, Vikram B. Overview of the American Society for Radiation Oncology-National Institutes of Health-American Association of Physicists in Medicine Workshop 2015: Exploring Opportunities for Radiation Oncology in the Era of Big Data. Int J Radiat Oncol Biol Phys. 2016 Jul 01; 95(3):873-879. PMID: 27302503; PMCID: PMC4965164.
    12. Kim DN, Straka C, Cho LC, Lotan Y, Yan J, Kavanagh B, Raben D, Cooley S, Brindle J, Xie XJ, Pistenmaa D, Timmerman R. Early and multiple PSA bounces can occur following high-dose prostate stereotactic body radiation therapy: Subset analysis of a phase 1/2 trial. Pract Radiat Oncol. 2017 Jan - Feb; 7(1):e43-e49. PMID: 27637137.
      View in: PubMed
    13. Rusthoven CG, Jones BL, Flaig TW, Crawford ED, Koshy M, Sher DJ, Mahmood U, Chen RC, Chapin BF, Kavanagh BD, Pugh TJ. Improved Survival With Prostate Radiation in Addition to Androgen Deprivation Therapy for Men With Newly Diagnosed Metastatic Prostate Cancer. J Clin Oncol. 2016 Aug 20; 34(24):2835-42. PMID: 27325855.
      View in: PubMed
    14. Amini A, Yeh N, Jones BL, Bedrick E, Vinogradskiy Y, Rusthoven CG, Amini A, Purcell WT, Karam SD, Kavanagh BD, Guntupalli SR, Fisher CM. Perioperative Mortality in Nonelderly Adult Patients With Cancer: A Population-based Study Evaluating Health Care Disparities in the United States According to Insurance Status. Am J Clin Oncol. 2016 Jun 08. PMID: 27281264.
      View in: PubMed
    15. Amini A, Jones BL, Yeh N, Guntupalli SR, Kavanagh BD, Karam SD, Fisher CM. Disparities in disease presentation in the four screenable cancers according to health insurance status. Public Health. 2016 Sep; 138:50-6. PMID: 27091437.
      View in: PubMed
    16. Deschamps A, Hall R, Grocott H, Mazer CD, Choi PT, Turgeon AF, de Medicis E, Bussières JS, Hudson C, Syed S, Seal D, Herd S, Lambert J, Denault A, Deschamps A, Mutch A, Turgeon A, Denault A, Todd A, Jerath A, Fayad A, Finnegan B, Kent B, Kennedy B, Cuthbertson BH, Kavanagh B, Warriner B, MacAdams C, Lehmann C, Fudorow C, Hudson C, McCartney C, McIsaac D, Dubois D, Campbell D, Mazer D, Neilpovitz D, Rosen D, Cheng D, Drapeau D, Dillane D, Tran D, Mckeen D, Wijeysundera D, Jacobsohn E, Couture E, de Medicis E, Alam F, Abdallah F, Ralley FE, Chung F, Lellouche F, Dobson G, Germain G, Djaiani G, Gilron I, Hare G, Bryson G, Clarke H, McDonald H, Roman-Smith H, Grocott H, Yang H, Douketis J, Paul J, Beaubien J, Bussières J, Pridham J, Armstrong JN, Parlow J, Murkin J, Gamble J, Duttchen K, Karkouti K, Turner K, Baghirzada L, Szabo L, Lalu M, Wasowicz M, Bautista M, Jacka M, Murphy M, Schmidt M, Verret M, Perrault MA, Beaudet N, Buckley N, Choi P, MacDougall P, Jones P, Drolet P, Beaulieu P, Taneja R, Martin R, Hall R, George R, Chun R, McMullen S, Beattie S, Sampson S, Choi S, Kowalski S, McCluskey S, Syed S, Boet S, Ramsay T, Saha T, Mutter T, Chowdhury T, Uppal V, Mckay W. Cerebral Oximetry Monitoring to Maintain Normal Cerebral Oxygen Saturation during High-risk Cardiac Surgery: A Randomized Controlled Feasibility Trial. Anesthesiology. 2016 Apr; 124(4):826-36. PMID: 26808629.
      View in: PubMed
    17. Hannan R, Tumati V, Xie XJ, Cho LC, Kavanagh BD, Brindle J, Raben D, Nanda A, Cooley S, Kim DW, Pistenmaa D, Lotan Y, Timmerman R. Stereotactic body radiation therapy for low and intermediate risk prostate cancer-Results from a multi-institutional clinical trial. Eur J Cancer. 2016 May; 59:142-51. PMID: 27035363.
      View in: PubMed
    18. Zhao J, Yorke ED, Li L, Kavanagh BD, Li XA, Das S, Miften M, Rimner A, Campbell J, Xue J, Jackson A, Grimm J, Milano MT, Spring Kong FM. Simple Factors Associated With Radiation-Induced Lung Toxicity After Stereotactic Body Radiation Therapy of the Thorax: A Pooled Analysis of 88 Studies. Int J Radiat Oncol Biol Phys. 2016 Aug 01; 95(5):1357-66. PMID: 27325482.
      View in: PubMed
    19. Amini A, Jones BL, Jackson MW, Rusthoven CG, Maroni P, Kavanagh BD, Raben D. Survival outcomes of combined external beam radiotherapy and brachytherapy vs. brachytherapy alone for intermediate-risk prostate cancer patients using the National Cancer Data Base. Brachytherapy. 2016 Mar-Apr; 15(2):136-46. PMID: 26825856.
      View in: PubMed
    20. Amini A, Kavanagh BD, Rusthoven CG. Improved survival with the addition of radiotherapy to androgen deprivation: questions answered and a review of current controversies in radiotherapy for non-metastatic prostate cancer. Ann Transl Med. 2016 Jan; 4(1):14. PMID: 26855950; PMCID: PMC4716946.
    21. Amini A, Rusthoven CG, Jones BL, Armstrong H, Raben D, Kavanagh BD. Survival outcomes of radiotherapy with or without androgen-deprivation therapy for patients with intermediate-risk prostate cancer using the National Cancer Data Base. Urol Oncol. 2016 Apr; 34(4):165.e1-9. PMID: 26699831.
      View in: PubMed
    22. Amini A, Jones B, Jackson MW, Yeh N, Waxweiler TV, Maroni P, Kavanagh BD, Raben D. Survival Outcomes of Dose-Escalated External Beam Radiotherapy versus Combined Brachytherapy for Intermediate and High Risk Prostate Cancer Using the National Cancer Data Base. J Urol. 2016 May; 195(5):1453-8. PMID: 26576709.
      View in: PubMed
    23. Chen RC, Gabriel PE, Kavanagh BD, McNutt TR. How Will Big Data Impact Clinical Decision Making and Precision Medicine in Radiation Therapy? Int J Radiat Oncol Biol Phys. 2016 Jul 01; 95(3):880-884. PMID: 26797536.
      View in: PubMed
    24. Diot Q, Kavanagh B, Vinogradskiy Y, Garg K, Gaspar L, Miften M. Lung deformations and radiation-induced regional lung collapse in patients treated with stereotactic body radiation therapy. Med Phys. 2015 Nov; 42(11):6477-87. PMID: 26520737.
      View in: PubMed
    25. Altoos B, Amini A, Yacoub M, Bourlon MT, Kessler EE, Flaig TW, Fisher CM, Kavanagh BD, Lam ET, Karam SD. Local Control Rates of Metastatic Renal Cell Carcinoma (RCC) to Thoracic, Abdominal, and Soft Tissue Lesions Using Stereotactic Body Radiotherapy (SBRT). Radiat Oncol. 2015 Oct 28; 10:218. PMID: 26510665; PMCID: PMC4625576.
    26. Johung KL, Yeh N, Desai NB, Williams TM, Lautenschlaeger T, Arvold ND, Ning MS, Attia A, Lovly CM, Goldberg S, Beal K, Yu JB, Kavanagh BD, Chiang VL, Camidge DR, Contessa JN. Extended Survival and Prognostic Factors for Patients With ALK-Rearranged Non-Small-Cell Lung Cancer and Brain Metastasis. J Clin Oncol. 2016 Jan 10; 34(2):123-9. PMID: 26438117.
      View in: PubMed
    27. Amini A, Jones BL, Yeh N, Rusthoven CG, Armstrong H, Kavanagh BD. Survival Outcomes of Whole-Pelvic Versus Prostate-Only Radiation Therapy for High-Risk Prostate Cancer Patients With Use of the National Cancer Data Base. Int J Radiat Oncol Biol Phys. 2015 Dec 01; 93(5):1052-63. PMID: 26581142.
      View in: PubMed
    28. Haffty BG, Beyer DC, Kavanagh BD. Radiation Oncologist Concerns About Increased Electronic Brachytherapy Use for Skin Cancer. JAMA Dermatol. 2015 Sep; 151(9):1036. PMID: 26177072.
      View in: PubMed
    29. Sheehan JP, Kavanagh BD, Asher A, Harbaugh RE. Inception of a national multidisciplinary registry for stereotactic radiosurgery. J Neurosurg. 2016 Jan; 124(1):155-62. PMID: 26252466.
      View in: PubMed
    30. Soltys SG, Kirkpatrick JP, Laack NN, Kavanagh BD, Breneman JC, Shih HA. Is Less, More? The Evolving Role of Radiation Therapy for Brain Metastases. Int J Radiat Oncol Biol Phys. 2015 Aug 01; 92(5):963-966. PMID: 26194672.
      View in: PubMed
    31. Chetty IJ, Martel MK, Jaffray DA, Benedict SH, Hahn SM, Berbeco R, Deye J, Jeraj R, Kavanagh B, Krishnan S, Lee N, Low DA, Mankoff D, Marks LB, Ollendorf D, Paganetti H, Ross B, Siochi RA, Timmerman RD, Wong JW. Technology for Innovation in Radiation Oncology. Int J Radiat Oncol Biol Phys. 2015 Nov 01; 93(3):485-92. PMID: 26460989; PMCID: PMC4610140 [Available on 11/01/16].
    32. Rusthoven CG, Kavanagh BD, Karam SD. Improved survival with stereotactic ablative radiotherapy (SABR) over lobectomy for early stage non-small cell lung cancer (NSCLC): addressing the fallout of disruptive randomized data. Ann Transl Med. 2015 Jul; 3(11):149. PMID: 26244136; PMCID: PMC4499662.
    33. Amini A, Altoos B, Bourlon MT, Bedrick E, Bhatia S, Kessler ER, Flaig TW, Fisher CM, Kavanagh BD, Lam ET, Karam SD. Local control rates of metastatic renal cell carcinoma (RCC) to the bone using stereotactic body radiation therapy: Is RCC truly radioresistant? Pract Radiat Oncol. 2015 Nov-Dec; 5(6):e589-96. PMID: 26142027; PMCID: PMC4706456.
    34. Carlson JA, Reddy K, Gaspar LE, Ney D, Kavanagh BD, Damek D, Lillehei K, Chen C. Hypofractionated-intensity modulated radiotherapy (hypo-IMRT) and temozolomide (TMZ) with or without bevacizumab (BEV) for newly diagnosed glioblastoma multiforme (GBM): a comparison of two prospective phase II trials. J Neurooncol. 2015 Jun; 123(2):251-7. PMID: 25920710.
      View in: PubMed
    35. Rusthoven CG, Carlson JA, Kavanagh BD. External Validation of the Benefit of Adjuvant Radiotherapy for Pathologic N1M0 Prostate Cancer. J Clin Oncol. 2015 Jun 10; 33(17):1987-8. PMID: 25847937.
      View in: PubMed
    36. Brennan D, Schubert L, Diot Q, Castillo R, Castillo E, Guerrero T, Martel MK, Linderman D, Gaspar LE, Miften M, Kavanagh BD, Vinogradskiy Y. Clinical validation of 4-dimensional computed tomography ventilation with pulmonary function test data. Int J Radiat Oncol Biol Phys. 2015 Jun 01; 92(2):423-9. PMID: 25817531; PMCID: PMC4431937.
    37. Rusthoven CG, Kavanagh BD. Considerations for observational research: in regard to Jagsi et al. Int J Radiat Oncol Biol Phys. 2015 Mar 01; 91(3):679-80. PMID: 25680608.
      View in: PubMed
    38. Ney DE, Carlson JA, Damek DM, Gaspar LE, Kavanagh BD, Kleinschmidt-DeMasters BK, Waziri AE, Lillehei KO, Reddy K, Chen C. Phase II trial of hypofractionated intensity-modulated radiation therapy combined with temozolomide and bevacizumab for patients with newly diagnosed glioblastoma. J Neurooncol. 2015 Mar; 122(1):135-43. PMID: 25524817.
      View in: PubMed
    39. Bourlon MT, Amini A, Kavanagh BD, Flaig TW. Pancreatic metastases from renal cell carcinoma treated with stereotactic body radiation therapy. Oncology (Williston Park). 2014 Nov; 28(11):1008-12. PMID: 25560737.
      View in: PubMed
    40. Hahn C, Kavanagh B, Bhatnagar A, Jacobson G, Lutz S, Patton C, Potters L, Steinberg M. Choosing wisely: the American Society for Radiation Oncology's top 5 list. Pract Radiat Oncol. 2014 Nov-Dec; 4(6):349-55. PMID: 25407853.
      View in: PubMed
    41. Iyengar P, Kavanagh BD, Wardak Z, Smith I, Ahn C, Gerber DE, Dowell J, Hughes R, Abdulrahman R, Camidge DR, Gaspar LE, Doebele RC, Bunn PA, Choy H, Timmerman R. Phase II trial of stereotactic body radiation therapy combined with erlotinib for patients with limited but progressive metastatic non-small-cell lung cancer. J Clin Oncol. 2014 Dec 01; 32(34):3824-30. PMID: 25349291.
      View in: PubMed
    42. Rusthoven CG, Carlson JA, Waxweiler TV, Dally MJ, Barón AE, Yeh N, Gaspar LE, Liu AK, Ney DE, Damek DM, Lillehei KO, Kavanagh BD. The impact of adjuvant radiation therapy for high-grade gliomas by histology in the United States population. Int J Radiat Oncol Biol Phys. 2014 Nov 15; 90(4):894-902. PMID: 25585784.
      View in: PubMed
    43. Amini A, Yeh N, Gaspar LE, Kavanagh B, Karam SD. Stereotactic body radiation therapy (SBRT) for lung cancer patients previously treated with conventional radiotherapy: a review. Radiat Oncol. 2014 Sep 19; 9:210. PMID: 25239200; PMCID: PMC4261522.
    44. Rusthoven CG, Waxweiler TV, DeWitt PE, Flaig TW, Raben D, Kavanagh BD. Gleason stratifications prognostic for survival in men receiving definitive external beam radiation therapy for localized prostate cancer. Urol Oncol. 2015 Feb; 33(2):71.e11-9. PMID: 25151595.
      View in: PubMed
    45. Kavanagh BD. Stereotactic body radiation therapy as a derivative of stereotactic radiosurgery: clinically independent but with enduring common themes. J Clin Oncol. 2014 Sep 10; 32(26):2827-31. PMID: 25113758; PMCID: PMC4152709.
    46. Kavanagh BD, Haffty BG, Tepper JE. Radiation oncology: a snapshot in time, 2014. J Clin Oncol. 2014 Sep 10; 32(26):2825-6. PMID: 25113774; PMCID: PMC4152708.
    47. Carlson JA, Nooruddin Z, Rusthoven C, Elias A, Borges VF, Diamond JR, Kavanagh B, Kabos P. Trastuzumab emtansine and stereotactic radiosurgery: an unexpected increase in clinically significant brain edema. Neuro Oncol. 2014 Jul; 16(7):1006-9. PMID: 24497407; PMCID: PMC4057140.
    48. Kim DW, Cho LC, Straka C, Christie A, Lotan Y, Pistenmaa D, Kavanagh BD, Nanda A, Kueplian P, Brindle J, Cooley S, Perkins A, Raben D, Xie XJ, Timmerman RD. Predictors of rectal tolerance observed in a dose-escalated phase 1-2 trial of stereotactic body radiation therapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2014 Jul 01; 89(3):509-17. PMID: 24929162.
      View in: PubMed
    49. Diot Q, Marks LB, Bentzen SM, Senan S, Kavanagh BD, Lawrence MV, Miften M, Palma DA. Comparison of radiation-induced normal lung tissue density changes for patients from multiple institutions receiving conventional or hypofractionated treatments. Int J Radiat Oncol Biol Phys. 2014 Jul 01; 89(3):626-32. PMID: 24929168.
      View in: PubMed
    50. Reddy K, Gaspar LE, Kavanagh BD, Chen C. Hypofractionated intensity-modulated radiotherapy with temozolomide chemotherapy may alter the patterns of failure in patients with glioblastoma multiforme. J Med Imaging Radiat Oncol. 2014 Dec; 58(6):714-21. PMID: 24975917.
      View in: PubMed
    51. Mohideen N, Kavanagh BD, Beyer D, Madhani S, Steinberg ML. Radiation oncology: a perspective on health reform and value-based initiatives. J Oncol Pract. 2014 Jul; 10(4):e212-4. PMID: 24893609.
      View in: PubMed
    52. Qi XS, Liu TX, Liu AK, Newman F, Rabinovitch R, Kavanagh B, Hu YA. Left-sided breast cancer irradiation using rotational and fixed-field radiotherapy. Med Dosim. 2014; 39(3):227-34. PMID: 24857697.
      View in: PubMed
    53. Vinogradskiy Y, Koo PJ, Castillo R, Castillo E, Guerrero T, Gaspar LE, Miften M, Kavanagh BD. Comparison of 4-dimensional computed tomography ventilation with nuclear medicine ventilation-perfusion imaging: a clinical validation study. Int J Radiat Oncol Biol Phys. 2014 May 01; 89(1):199-205. PMID: 24725702; PMCID: PMC4121964.
    54. Rusthoven CG, Carlson JA, Waxweiler TV, Raben D, Dewitt PE, Crawford ED, Maroni PD, Kavanagh BD. The impact of definitive local therapy for lymph node-positive prostate cancer: a population-based study. Int J Radiat Oncol Biol Phys. 2014 Apr 01; 88(5):1064-73. PMID: 24661660.
      View in: PubMed
    55. Rusthoven CG, Carlson JA, Waxweiler TV, Yeh N, Raben D, Flaig TW, Kavanagh BD. The prognostic significance of Gleason scores in metastatic prostate cancer. Urol Oncol. 2014 Jul; 32(5):707-13. PMID: 24629494.
      View in: PubMed
    56. Gan GN, Weickhardt AJ, Scheier B, Doebele RC, Gaspar LE, Kavanagh BD, Camidge DR. Stereotactic radiation therapy can safely and durably control sites of extra-central nervous system oligoprogressive disease in anaplastic lymphoma kinase-positive lung cancer patients receiving crizotinib. Int J Radiat Oncol Biol Phys. 2014 Mar 15; 88(4):892-8. PMID: 24462383; PMCID: PMC4160890.
    57. Kavanagh BD, Rabinovitch R, Mohideen N. Improved cosmesis in early breast cancer using conformal radiotherapy. J Clin Oncol. 2013 Dec 20; 31(36):4483-4. PMID: 24248685.
      View in: PubMed
    58. Jones BL, Gan G, Kavanagh B, Miften M. Effect of endorectal balloon positioning errors on target deformation and dosimetric quality during prostate SBRT. Phys Med Biol. 2013 Nov 21; 58(22):7995-8006. PMID: 24169860.
      View in: PubMed
    59. Altunbas C, Howells C, Proper M, Reddy K, Gan G, DeWitt P, Kavanagh B, Schefter T, Miften M. Evaluation of threshold and gradient based (18)F-fluoro-deoxy-2-glucose hybrid positron emission tomographic image segmentation methods for liver tumor delineation. Pract Radiat Oncol. 2014 Jul-Aug; 4(4):217-25. PMID: 25012829.
      View in: PubMed
    60. Altunbas C, Kavanagh B, Dzingle W, Stuhr K, Gaspar L, Miften M. Dosimetric errors during treatment of centrally located lung tumors with stereotactic body radiation therapy: Monte Carlo evaluation of tissue inhomogeneity corrections. Med Dosim. 2013; 38(4):436-41. PMID: 24119416.
      View in: PubMed
    61. Vinogradskiy Y, Diot Q, Kavanagh B, Schefter T, Gaspar L, Miften M. Spatial and dose-response analysis of fibrotic lung changes after stereotactic body radiation therapy. Med Phys. 2013 Aug; 40(8):081712. PMID: 23927309.
      View in: PubMed
    62. Gibbs IC, Haas-Kogan D, Terezakis S, Kavanagh BD. The subventricular zone neural progenitor cell hypothesis in glioblastoma: epiphany, Trojan Horse, or Cheshire fact? Int J Radiat Oncol Biol Phys. 2013 Jul 15; 86(4):606-8. PMID: 23773389.
      View in: PubMed
    63. Reddy K, Gaspar LE, Kavanagh BD, Waziri A, Damek DM, Ney D, Lillehei KO, Chen C. Prospective evaluation of health-related quality of life in patients with glioblastoma multiforme treated on a phase II trial of hypofractionated IMRT with temozolomide. J Neurooncol. 2013 Aug; 114(1):111-6. PMID: 23729276.
      View in: PubMed
    64. Diot Q, Bentzen S, Palma D, Marks L, Senan S, Kavanagh B, Miften M, Lawrence M. TH-A-WAB-11: A Novel Method to Determine Alpha/beta for Irradiated Normal Lung Tissue Using Computed Tomography Scans. Med Phys. 2013 Jun; 40(6Part31):522. PMID: 28519661.
      View in: PubMed
    65. Altunbas C, Jones B, Kavanagh B, Miften M. WE-G-134-01: A Novel Method to Correct Scatter and Metal Artifacts in Kilovoltage CBCT Using Megavoltage Projections. Med Phys. 2013 Jun; 40(6Part31):512. PMID: 28519676.
      View in: PubMed
    66. Amin NP, Miften M, Thornton D, Ryan N, Kavanagh B, Gaspar LE. Effect of induction chemotherapy on estimated risk of radiation pneumonitis in bulky non-small cell lung cancer. Med Dosim. 2013; 38(3):320-6. PMID: 23611631.
      View in: PubMed
    67. Cho LC, Timmerman R, Kavanagh B. Hypofractionated external-beam radiotherapy for prostate cancer. Prostate Cancer. 2013; 2013:103547. PMID: 23533777; PMCID: PMC3606774.
    68. Hartford AC, Galvin JM, Beyer DC, Eichler TJ, Ibbott GS, Kavanagh B, Schultz CJ, Rosenthal SA. American College of Radiology (ACR) and American Society for Radiation Oncology (ASTRO) Practice Guideline for Intensity-modulated Radiation Therapy (IMRT). Am J Clin Oncol. 2012 Dec; 35(6):612-7. PMID: 23165357.
      View in: PubMed
    69. Weickhardt AJ, Scheier B, Burke JM, Gan G, Lu X, Bunn PA, Aisner DL, Gaspar LE, Kavanagh BD, Doebele RC, Camidge DR. Local ablative therapy of oligoprogressive disease prolongs disease control by tyrosine kinase inhibitors in oncogene-addicted non-small-cell lung cancer. J Thorac Oncol. 2012 Dec; 7(12):1807-14. PMID: 23154552; PMCID: PMC3506112.
    70. Kavanagh BD, Ibbott GS, Orton CG. Point/counterpoint: physicists who are responsible for high-tech radiotherapy procedures should have to be specially credentialed. Med Phys. 2012 Dec; 39(12):7181-4. PMID: 23231268.
      View in: PubMed
    71. Westerly DC, Schefter TE, Kavanagh BD, Chao E, Lucas D, Flynn RT, Miften M. High-dose MVCT image guidance for stereotactic body radiation therapy. Med Phys. 2012 Aug; 39(8):4812-9. PMID: 22894407.
      View in: PubMed
    72. Howells CC, Stinauer MA, Diot Q, Westerly DC, Schefter TE, Kavanagh BD, Miften M. Normal liver tissue density dose response in patients treated with stereotactic body radiation therapy for liver metastases. Int J Radiat Oncol Biol Phys. 2012 Nov 01; 84(3):e441-6. PMID: 22682809.
      View in: PubMed
    73. Jones BL, Gan G, Diot Q, Kavanagh B, Timmerman RD, Miften M. Dosimetric and deformation effects of image-guided interventions during stereotactic body radiation therapy of the prostate using an endorectal balloon. Med Phys. 2012 Jun; 39(6):3080-8. PMID: 22755693.
      View in: PubMed
    74. Jones B, Altunbas C, Kavanagh B, Miften M. WE-G-217BCD-08: Image Quality Effects of Dynamic Iodine Concentrations for Contrast-Enhanced Cone-Beam CT. Med Phys. 2012 Jun; 39(6Part28):3974. PMID: 28519608.
      View in: PubMed
    75. Diot Q, Kavanagh B, Schefter T, Gaspar L, Stuhr K, Miften M. Regional normal lung tissue density changes in patients treated with stereotactic body radiation therapy for lung tumors. Int J Radiat Oncol Biol Phys. 2012 Nov 15; 84(4):1024-30. PMID: 22583607.
      View in: PubMed
    76. Stinauer MA, Diot Q, Westerly DC, Schefter TE, Kavanagh BD. Fluorodeoxyglucose positron emission tomography response and normal tissue regeneration after stereotactic body radiotherapy to liver metastases. Int J Radiat Oncol Biol Phys. 2012 Aug 01; 83(5):e613-8. PMID: 22494588.
      View in: PubMed
    77. Reddy K, Damek D, Gaspar LE, Ney D, Waziri A, Lillehei K, Stuhr K, Kavanagh BD, Chen C. Phase II trial of hypofractionated IMRT with temozolomide for patients with newly diagnosed glioblastoma multiforme. Int J Radiat Oncol Biol Phys. 2012 Nov 01; 84(3):655-60. PMID: 22483738.
      View in: PubMed
    78. Høyer M, Swaminath A, Bydder S, Lock M, Méndez Romero A, Kavanagh B, Goodman KA, Okunieff P, Dawson LA. Radiotherapy for liver metastases: a review of evidence. Int J Radiat Oncol Biol Phys. 2012 Mar 01; 82(3):1047-57. PMID: 22284028.
      View in: PubMed
    79. Diot Q, Kavanagh B, Timmerman R, Miften M. Biological-based optimization and volumetric modulated arc therapy delivery for stereotactic body radiation therapy. Med Phys. 2012 Jan; 39(1):237-45. PMID: 22225293.
      View in: PubMed
    80. Stinauer MA, Kavanagh BD, Mitchell JD. Presumed early-stage lung cancer treated with stereotactic body radiation therapy in a medically inoperable patient with multiple connective tissue disorders. Pract Radiat Oncol. 2012 Oct-Dec; 2(4):e133-6. PMID: 24674176.
      View in: PubMed
    81. Schefter TE, Kavanagh BD. Radiation therapy for liver metastases. Semin Radiat Oncol. 2011 Oct; 21(4):264-70. PMID: 21939855.
      View in: PubMed
    82. Guha C, Kavanagh BD. Hepatic radiation toxicity: avoidance and amelioration. Semin Radiat Oncol. 2011 Oct; 21(4):256-63. PMID: 21939854; PMCID: PMC3434677.
    83. Solberg TD, Balter JM, Benedict SH, Fraass BA, Kavanagh B, Miyamoto C, Pawlicki T, Potters L, Yamada Y. Quality and safety considerations in stereotactic radiosurgery and stereotactic body radiation therapy: Executive summary. Pract Radiat Oncol. 2012 Jan-Mar; 2(1):2-9. PMID: 25740120; PMCID: PMC3808746.
    84. Amin NP, Miften M, Kavanagh B, Raben D, Camidge DR, Thornton D, Rochford N, Gaspar LE. Impact of induction chemotherapy on estimated risk of radiation pneumonitis in small cell lung cancer. J Thorac Oncol. 2011 Sep; 6(9):1553-62. PMID: 21642862.
      View in: PubMed
    85. Kavanagh BD, Raben D. Back to the future: a proton pro/con. Oncology (Williston Park). 2011 Jun; 25(7):657, 660, 662-3. PMID: 21888267.
      View in: PubMed
    86. Kavanagh BD, Timmerman R, Meyer JL. The expanding roles of stereotactic body radiation therapy and oligofractionation: toward a new practice of radiotherapy. Front Radiat Ther Oncol. 2011; 43:370-81. PMID: 21625163.
      View in: PubMed
    87. Loo BW, Kavanagh BD, Meyer JL. Motion management and image guidance for thoracic tumor radiotherapy: clinical treatment programs. Front Radiat Ther Oncol. 2011; 43:271-91. PMID: 21625158.
      View in: PubMed
    88. Kavanagh BD, Miften M, Rabinovitch RA. Advances in treatment techniques: stereotactic body radiation therapy and the spread of hypofractionation. Cancer J. 2011 May-Jun; 17(3):177-81. PMID: 21610471.
      View in: PubMed
    89. Stinauer MA, Kavanagh BD, Schefter TE, Gonzalez R, Flaig T, Lewis K, Robinson W, Chidel M, Glode M, Raben D. Stereotactic body radiation therapy for melanoma and renal cell carcinoma: impact of single fraction equivalent dose on local control. Radiat Oncol. 2011 Apr 08; 6:34. PMID: 21477295; PMCID: PMC3094365.
    90. Chang DT, Swaminath A, Kozak M, Weintraub J, Koong AC, Kim J, Dinniwell R, Brierley J, Kavanagh BD, Dawson LA, Schefter TE. Stereotactic body radiotherapy for colorectal liver metastases: a pooled analysis. Cancer. 2011 Sep 01; 117(17):4060-9. PMID: 21432842.
      View in: PubMed
    91. Loo BW, Chang JY, Dawson LA, Kavanagh BD, Koong AC, Senan S, Timmerman RD. Stereotactic ablative radiotherapy: what's in a name? Pract Radiat Oncol. 2011 Jan-Mar; 1(1):38-9. PMID: 24673868.
      View in: PubMed
    92. Heinzerling JH, Kavanagh B, Timmerman RD. Stereotactic ablative radiation therapy for primary lung tumors. Cancer J. 2011 Jan-Feb; 17(1):28-32. PMID: 21263264.
      View in: PubMed
    93. Fields EC, Damek D, Gaspar LE, Liu AK, Kavanagh BD, Waziri A, Lillehei K, Chen C. Phase I dose escalation trial of vandetanib with fractionated radiosurgery in patients with recurrent malignant gliomas. Int J Radiat Oncol Biol Phys. 2012 Jan 01; 82(1):51-7. PMID: 21035955.
      View in: PubMed
    94. Chen C, Damek D, Gaspar LE, Waziri A, Lillehei K, Kleinschmidt-DeMasters BK, Robischon M, Stuhr K, Rusthoven KE, Kavanagh BD. Phase I trial of hypofractionated intensity-modulated radiotherapy with temozolomide chemotherapy for patients with newly diagnosed glioblastoma multiforme. Int J Radiat Oncol Biol Phys. 2011 Nov 15; 81(4):1066-74. PMID: 20932651.
      View in: PubMed
    95. Rusthoven KE, Olsen C, Franklin W, Kleinschmidt-DeMasters BK, Kavanagh BD, Gaspar LE, Lillehei K, Waziri A, Damek DM, Chen C. Favorable prognosis in patients with high-grade glioma with radiation necrosis: the University of Colorado reoperation series. Int J Radiat Oncol Biol Phys. 2011 Sep 01; 81(1):211-7. PMID: 20732762.
      View in: PubMed
    96. Benedict SH, Yenice KM, Followill D, Galvin JM, Hinson W, Kavanagh B, Keall P, Lovelock M, Meeks S, Papiez L, Purdie T, Sadagopan R, Schell MC, Salter B, Schlesinger DJ, Shiu AS, Solberg T, Song DY, Stieber V, Timmerman R, Tomé WA, Verellen D, Wang L, Yin FF. Stereotactic body radiation therapy: the report of AAPM Task Group 101. Med Phys. 2010 Aug; 37(8):4078-101. PMID: 20879569.
      View in: PubMed
    97. Diot Q, Olsen C, Kavanagh B, Raben D, Miften M. Dosimetric effect of online image-guided anatomical interventions for postprostatectomy cancer patients. Int J Radiat Oncol Biol Phys. 2011 Feb 01; 79(2):623-32. PMID: 20643519.
      View in: PubMed
    98. Zhang L, Kavanagh BD, Thorburn AM, Camidge DR. Preclinical and clinical estimates of the basal apoptotic rate of a cancer predict the amount of apoptosis induced by subsequent proapoptotic stimuli. Clin Cancer Res. 2010 Sep 01; 16(17):4478-89. PMID: 20630997.
      View in: PubMed
    99. Dawson LA, Kavanagh BD, Paulino AC, Das SK, Miften M, Li XA, Pan C, Ten Haken RK, Schultheiss TE. Radiation-associated kidney injury. Int J Radiat Oncol Biol Phys. 2010 Mar 01; 76(3 Suppl):S108-15. PMID: 20171504.
      View in: PubMed
    100. Flaig TW, Kondo KL, La Rosa FG, Kavanagh B, Crawford ED. A young woman with multiple kidney lesions. Oncology (Williston Park). 2010 Mar; 24(3):282-6. PMID: 20394141.
      View in: PubMed
    101. Kavanagh BD, Pan CC, Dawson LA, Das SK, Li XA, Ten Haken RK, Miften M. Radiation dose-volume effects in the stomach and small bowel. Int J Radiat Oncol Biol Phys. 2010 Mar 01; 76(3 Suppl):S101-7. PMID: 20171503.
      View in: PubMed
    102. Pan CC, Kavanagh BD, Dawson LA, Li XA, Das SK, Miften M, Ten Haken RK. Radiation-associated liver injury. Int J Radiat Oncol Biol Phys. 2010 Mar 01; 76(3 Suppl):S94-100. PMID: 20171524; PMCID: PMC4388033.
    103. Potters L, Gaspar LE, Kavanagh B, Galvin JM, Hartford AC, Hevezi JM, Kupelian PA, Mohiden N, Samuels MA, Timmerman R, Tripuraneni P, Vlachaki MT, Xing L, Rosenthal SA. American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) practice guidelines for image-guided radiation therapy (IGRT). Int J Radiat Oncol Biol Phys. 2010 Feb 01; 76(2):319-25. PMID: 20117284.
      View in: PubMed
    104. Diot Q, Olsen C, Kavanagh B, Raben D, Miften M. Impact of anatomical interventions on the localization of post-prostatectomy cancer patients. Med Phys. 2010 Feb; 37(2):629-37. PMID: 20229872.
      View in: PubMed
    105. Potters L, Kavanagh B, Galvin JM, Hevezi JM, Janjan NA, Larson DA, Mehta MP, Ryu S, Steinberg M, Timmerman R, Welsh JS, Rosenthal SA. American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) practice guideline for the performance of stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys. 2010 Feb 01; 76(2):326-32. PMID: 20117285.
      View in: PubMed
    106. Pugh TJ, Ballonoff A, Rusthoven KE, McCammon R, Kavanagh B, Newman F, Rabinovitch R. Cardiac mortality in patients with stage I and II diffuse large B-cell lymphoma treated with and without radiation: a surveillance, epidemiology, and end-results analysis. Int J Radiat Oncol Biol Phys. 2010 Mar 01; 76(3):845-9. PMID: 19515509.
      View in: PubMed
    107. Dunlap NE, Cai J, Biedermann GB, Yang W, Benedict SH, Sheng K, Schefter TE, Kavanagh BD, Larner JM. Chest wall volume receiving >30 Gy predicts risk of severe pain and/or rib fracture after lung stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys. 2010 Mar 01; 76(3):796-801. PMID: 19427740.
      View in: PubMed
    108. McCammon R, Rusthoven KE, Kavanagh B, Newell S, Newman F, Raben D. Toxicity assessment of pelvic intensity-modulated radiotherapy with hypofractionated simultaneous integrated boost to prostate for intermediate- and high-risk prostate cancer. Int J Radiat Oncol Biol Phys. 2009 Oct 01; 75(2):413-20. PMID: 19362783.
      View in: PubMed
    109. Rabinovitch R, Kavanagh B. Double Helix of breast cancer therapy: intertwining the Halsted and Fisher hypotheses. J Clin Oncol. 2009 May 20; 27(15):2422-3. PMID: 19349536.
      View in: PubMed
    110. Rusthoven KE, Kavanagh BD, Cardenes H, Stieber VW, Burri SH, Feigenberg SJ, Chidel MA, Pugh TJ, Franklin W, Kane M, Gaspar LE, Schefter TE. Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases. J Clin Oncol. 2009 Apr 01; 27(10):1572-8. PMID: 19255321.
      View in: PubMed
    111. Rusthoven KE, Kavanagh BD, Burri SH, Chen C, Cardenes H, Chidel MA, Pugh TJ, Kane M, Gaspar LE, Schefter TE. Multi-institutional phase I/II trial of stereotactic body radiation therapy for lung metastases. J Clin Oncol. 2009 Apr 01; 27(10):1579-84. PMID: 19255320.
      View in: PubMed
    112. Rusthoven KE, Hammerman SF, Kavanagh BD, Birtwhistle MJ, Stares M, Camidge DR. Is there a role for consolidative stereotactic body radiation therapy following first-line systemic therapy for metastatic lung cancer? A patterns-of-failure analysis. Acta Oncol. 2009; 48(4):578-83. PMID: 19373699.
      View in: PubMed
    113. Hartford AC, Palisca MG, Eichler TJ, Beyer DC, Devineni VR, Ibbott GS, Kavanagh B, Kent JS, Rosenthal SA, Schultz CJ, Tripuraneni P, Gaspar LE. American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) Practice Guidelines for Intensity-Modulated Radiation Therapy (IMRT). Int J Radiat Oncol Biol Phys. 2009 Jan 01; 73(1):9-14. PMID: 19100920.
      View in: PubMed
    114. Schwer AL, Kavanagh BD, McCammon R, Gaspar LE, Kleinschmidt-De Masters BK, Stuhr K, Chen C. Radiographic and histopathologic observations after combined EGFR inhibition and hypofractionated stereotactic radiosurgery in patients with recurrent malignant gliomas. Int J Radiat Oncol Biol Phys. 2009 Apr 01; 73(5):1352-7. PMID: 19013723.
      View in: PubMed
    115. Olsen CC, Welsh J, Kavanagh BD, Franklin W, McCarter M, Cardenes HR, Gaspar LE, Schefter TE. Microscopic and macroscopic tumor and parenchymal effects of liver stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys. 2009 Apr 01; 73(5):1414-24. PMID: 18990508.
      View in: PubMed
    116. Kavanagh B. Clinical experience shows that catastrophic late effects associated with ablative fractionation can be avoided by technological innovation. Semin Radiat Oncol. 2008 Oct; 18(4):223-8. PMID: 18725107.
      View in: PubMed
    117. McCammon R, Schefter TE, Gaspar LE, Zaemisch R, Gravdahl D, Kavanagh B. Observation of a dose-control relationship for lung and liver tumors after stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys. 2009 Jan 01; 73(1):112-8. PMID: 18786780.
      View in: PubMed
    118. Kavanagh BD, Newman F. Toward a unified survival curve: in regard to Park et al. (IntJ Radiat Oncol Biol Phys 2008;70:847-852) and Krueger et al. (Int J Radiat Oncol Biol Phys 2007;69:1262-1271). Int J Radiat Oncol Biol Phys. 2008 Jul 01; 71(3):958-9. PMID: 18514788.
      View in: PubMed
    119. Kavanagh B, O'Brien S, Lee D, Hou Y, Weinberg V, Rini B, Allison JP, Small EJ, Fong L. CTLA4 blockade expands FoxP3+ regulatory and activated effector CD4+ T cells in a dose-dependent fashion. Blood. 2008 Aug 15; 112(4):1175-83. PMID: 18523152; PMCID: PMC2515138.
    120. Ballonoff A, Kavanagh B, McCarter M, Kane M, Pearlman N, Nash R, Shah RJ, Raben D, Schefter TE. Preoperative capecitabine and accelerated intensity-modulated radiotherapy in locally advanced rectal cancer: a phase II trial. Am J Clin Oncol. 2008 Jun; 31(3):264-70. PMID: 18525306.
      View in: PubMed
    121. Ballonoff A, Rusthoven KE, Schwer A, McCammon R, Kavanagh B, Bassetti M, Newman F, Rabinovitch R. Outcomes and effect of radiotherapy in patients with stage I or II diffuse large B-cell lymphoma: a surveillance, epidemiology, and end results analysis. Int J Radiat Oncol Biol Phys. 2008 Dec 01; 72(5):1465-71. PMID: 18495371.
      View in: PubMed
    122. Solberg TD, Kavanagh BD, Medin PM. Stereotactic body radiation therapy: a new paradigm in radiotherapy management of cancer. J Am Coll Radiol. 2008 May; 5(5):673-7. PMID: 18442775.
      View in: PubMed
    123. Kudchadkar R, Gonzalez R, Lewis K, Treichel K, Hammerman S, Robinson W, Fitzpatrick J, Gonzalez R, Kavanagh B, Rusthoven K. A case of Merkel cell carcinoma. Oncology (Williston Park). 2008 Mar; 22(3):322-8. PMID: 18494357.
      View in: PubMed
    124. Rusthoven KE, Flaig TW, Raben D, Kavanagh BD. High incidence of lung cancer after non-muscle-invasive transitional cell carcinoma of the bladder: implications for screening trials. Clin Lung Cancer. 2008 Mar; 9(2):106-11. PMID: 18501097.
      View in: PubMed
    125. Hou Y, Kavanagh B, Fong L. Distinct CD8+ T cell repertoires primed with agonist and native peptides derived from a tumor-associated antigen. J Immunol. 2008 Feb 01; 180(3):1526-34. PMID: 18209048.
      View in: PubMed
    126. Ballonoff A, Kavanagh B, Nash R, Drabkin H, Trotter J, Costa L, Rabinovitch R. Hodgkin lymphoma-related vanishing bile duct syndrome and idiopathic cholestasis: statistical analysis of all published cases and literature review. Acta Oncol. 2008; 47(5):962-70. PMID: 17906981.
      View in: PubMed
    127. Newman F, Asadi-Zeydabadi M, Durairaj VD, Ding M, Stuhr K, Kavanagh B. Visual sensations during megavoltage radiotherapy to the orbit attributable to Cherenkov radiation. Med Phys. 2008 Jan; 35(1):77-80. PMID: 18293564.
      View in: PubMed
    128. Rusthoven K, Chen C, Raben D, Kavanagh B. Use of external beam radiotherapy is associated with reduced incidence of second primary head and neck cancer: a SEER database analysis. Int J Radiat Oncol Biol Phys. 2008 May 01; 71(1):192-8. PMID: 18078720.
      View in: PubMed
    129. Schwer AL, Damek DM, Kavanagh BD, Gaspar LE, Lillehei K, Stuhr K, Chen C. A phase I dose-escalation study of fractionated stereotactic radiosurgery in combination with gefitinib in patients with recurrent malignant gliomas. Int J Radiat Oncol Biol Phys. 2008 Mar 15; 70(4):993-1001. PMID: 17967517.
      View in: PubMed
    130. Kavanagh B, Ko A, Venook A, Margolin K, Zeh H, Lotze M, Schillinger B, Liu W, Lu Y, Mitsky P, Schilling M, Bercovici N, Loudovaris M, Guillermo R, Lee SM, Bender J, Mills B, Fong L. Vaccination of metastatic colorectal cancer patients with matured dendritic cells loaded with multiple major histocompatibility complex class I peptides. J Immunother. 2007 Oct; 30(7):762-72. PMID: 17893568.
      View in: PubMed
    131. Timmerman RD, Park C, Kavanagh BD. The North American experience with stereotactic body radiation therapy in non-small cell lung cancer. J Thorac Oncol. 2007 Jul; 2(7 Suppl 3):S101-12. PMID: 17603304.
      View in: PubMed
    132. Flaig T, Crawford ED, Kavanagh B, Lucia S, La Rosa F, Barqawi A, Crighton F, Glodé LM. Prostate cancer in a man with multiple previous cancers. Oncology (Williston Park). 2007 Apr; 21(5):611-4. PMID: 17536345.
      View in: PubMed
    133. Timmerman RD, Kavanagh BD, Cho LC, Papiez L, Xing L. Stereotactic body radiation therapy in multiple organ sites. J Clin Oncol. 2007 Mar 10; 25(8):947-52. PMID: 17350943.
      View in: PubMed
    134. Kavanagh BD, Kelly K, Kane M. The promise of stereotactic body radiation therapy in a new era of oncology. Front Radiat Ther Oncol. 2007; 40:340-51. PMID: 17641518.
      View in: PubMed
    135. Timmerman R, Abdulrahman R, Kavanagh BD, Meyer JL. Lung cancer: a model for implementing stereotactic body radiation therapy into practice. Front Radiat Ther Oncol. 2007; 40:368-85. PMID: 17641520.
      View in: PubMed
    136. Kavanagh BD, Scheftera TE, Wersäll PJ. Liver, renal, and retroperitoneal tumors: stereotactic radiotherapy. Front Radiat Ther Oncol. 2007; 40:415-26. PMID: 17641524.
      View in: PubMed
    137. Beheiry HE, Kavanagh B. Is propofol neurotoxic to the developing brain? Can J Anaesth. 2006 Nov; 53(11):1069. PMID: 27771905.
      View in: PubMed
    138. Crawford ED, Kavanagh BD. The role of alpha-blockers in the management of lower urinary tract symptoms in prostate cancer patients treated with radiation therapy. Am J Clin Oncol. 2006 Oct; 29(5):517-23. PMID: 17023790.
      View in: PubMed
    139. Baisden JM, Reish AG, Sheng K, Larner JM, Kavanagh BD, Read PW. Dose as a function of liver volume and planning target volume in helical tomotherapy, intensity-modulated radiation therapy-based stereotactic body radiation therapy for hepatic metastasis. Int J Radiat Oncol Biol Phys. 2006 Oct 01; 66(2):620-5. PMID: 16904845.
      View in: PubMed
    140. Kavanagh BD, Raben D. Toward a unified target theory in oncology. Future Oncol. 2006 Aug; 2(4):435-6. PMID: 16922608.
      View in: PubMed
    141. Kavanagh BD, Ding M, Schefter TE, Stuhr K, Newman FA. The dosimetric effect of inhomogeneity correction in dynamic conformal arc stereotactic body radiation therapy for lung tumors. J Appl Clin Med Phys. 2006 May 25; 7(2):58-63. PMID: 17533331.
      View in: PubMed
    142. Kavanagh BD, McGarry RC, Timmerman RD. Extracranial radiosurgery (stereotactic body radiation therapy) for oligometastases. Semin Radiat Oncol. 2006 Apr; 16(2):77-84. PMID: 16564443.
      View in: PubMed
    143. Poznanovic SA, Cass SP, Kavanagh BD. Short-term tumor control and acute toxicity after stereotactic radiosurgery for glomus jugulare tumors. Otolaryngol Head Neck Surg. 2006 Mar; 134(3):437-42. PMID: 16500441.
      View in: PubMed
    144. Kavanagh BD, Timmerman RD. Stereotactic radiosurgery and stereotactic body radiation therapy: an overview of technical considerations and clinical applications. Hematol Oncol Clin North Am. 2006 Feb; 20(1):87-95. PMID: 16580558.
      View in: PubMed
    145. Kavanagh BD, Schefter TE, Cardenes HR, Stieber VW, Raben D, Timmerman RD, McCarter MD, Burri S, Nedzi LA, Sawyer TE, Gaspar LE. Interim analysis of a prospective phase I/II trial of SBRT for liver metastases. Acta Oncol. 2006; 45(7):848-55. PMID: 16982549.
      View in: PubMed
    146. Schefter TE, Kavanagh BD, Timmerman RD, Cardenes HR, Baron A, Gaspar LE. A phase I trial of stereotactic body radiation therapy (SBRT) for liver metastases. Int J Radiat Oncol Biol Phys. 2005 Aug 01; 62(5):1371-8. PMID: 16029795.
      View in: PubMed
    147. Timmerman RD, Kavanagh BD. Stereotactic body radiation therapy. Curr Probl Cancer. 2005 May-Jun; 29(3):120-57. PMID: 16059851.
      View in: PubMed
    148. Song DY, Kavanagh BD, Benedict SH, Schefter T. Stereotactic body radiation therapy. Rationale, techniques, applications, and optimization. Oncology (Williston Park). 2004 Oct; 18(11):1419-30; discussion 1430, 1432, 1435-6. PMID: 15609470.
      View in: PubMed
    149. Kavanagh BD. The emperor's new isodose curves. Med Phys. 2003 Sep; 30(9):2559-60. PMID: 14528979.
      View in: PubMed
    150. Arthur DW, Koo D, Zwicker RD, Tong S, Bear HD, Kaplan BJ, Kavanagh BD, Warwicke LA, Holdford D, Amir C, Archer KJ, Schmidt-Ullrich RK. Partial breast brachytherapy after lumpectomy: low-dose-rate and high-dose-rate experience. Int J Radiat Oncol Biol Phys. 2003 Jul 01; 56(3):681-9. PMID: 12788173.
      View in: PubMed
    151. Kavanagh BD, Timmerman RD, Benedict SH, Wu Q, Schefter TE, Stuhr K, McCourt S, Newman F, Cardinale RM, Gaspar LF. How should we describe the radioblologic effect of extracranial stereotactic radlosurgery: equivalent uniform dose or tumor control probability? Med Phys. 2003 Mar; 30(3):321-4. PMID: 12674231.
      View in: PubMed
    152. Eley KW, Benedict SH, Chung TD, Kavanagh BD, Broaddus WC, Schmidt-Ullrich RK, Lin PS. The effects of pentoxifylline on the survival of human glioma cells with continuous and intermittent stereotactic radiosurgery irradiation. Int J Radiat Oncol Biol Phys. 2002 Oct 01; 54(2):542-50. PMID: 12243834.
      View in: PubMed
    153. Kavanagh BD, Schefter TE, Wu Q, Tong S, Newman F, Arnfield M, Benedict SH, McCourt S, Mohan R. Clinical application of intensity-modulated radiotherapy for locally advanced cervical cancer. Semin Radiat Oncol. 2002 Jul; 12(3):260-71. PMID: 12118391.
      View in: PubMed
    154. Kavanagh BD, Secomb TW, Hsu R, Lin PS, Venitz J, Dewhirst MW. A theoretical model for the effects of reduced hemoglobin-oxygen affinity on tumor oxygenation. Int J Radiat Oncol Biol Phys. 2002 May 01; 53(1):172-9. PMID: 12007957.
      View in: PubMed
    155. Arnfield MR, Lin PS, Manning MA, Arthur DW, Kavanagh BD, Zwicker RD, Schmidt-Ullrich RK. The effect of high-dose-rate brachytherapy dwell sequence on cell survival. Int J Radiat Oncol Biol Phys. 2002 Mar 01; 52(3):850-7. PMID: 11849811.
      View in: PubMed
    156. Schefter TE, Kavanagh BD, Wu Q, Tong S, Newman F, Mccourt S, Arnfield M, Benedict S, Mohan R. Technical considerations in the application of intensity-modulated radiotherapy as a concomitant integrated boost for locally-advanced cervix cancer. Med Dosim. 2002; 27(2):177-84. PMID: 12074470.
      View in: PubMed
    157. Manning MA, Wu Q, Cardinale RM, Mohan R, Lauve AD, Kavanagh BD, Morris MM, Schmidt-Ullrich RK. The effect of setup uncertainty on normal tissue sparing with IMRT for head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2001 Dec 01; 51(5):1400-9. PMID: 11728701.
      View in: PubMed
    158. Kavanagh BD, Fischer BA, Segreti EM, Wheelock JB, Boardman C, Roseff SD, Cardinale RM, Benedict SH, Goram AL. Cost analysis of erythropoietin versus blood transfusions for cervical cancer patients receiving chemoradiotherapy. Int J Radiat Oncol Biol Phys. 2001 Oct 01; 51(2):435-41. PMID: 11567818.
      View in: PubMed
    159. Kavanagh BD, Segreti EM, Koo D, Amir C, Arthur D, Wheelock J, Cardinale RM, Schmidt-Ullrich RK. Long-term local control and survival after concomitant boost accelerated radiotherapy for locally advanced cervix cancer. Am J Clin Oncol. 2001 Apr; 24(2):113-9. PMID: 11319281.
      View in: PubMed
    160. Kavanagh BD, Khandelwal SR, Schmidt-Ullrich RK, Roberts JD, Shaw EG, Pearlman AD, Venitz J, Dusenbery KE, Abraham DJ, Gerber MJ. A phase I study of RSR13, a radiation-enhancing hemoglobin modifier: tolerance of repeated intravenous doses and correlation of pharmacokinetics with pharmacodynamics. Int J Radiat Oncol Biol Phys. 2001 Mar 15; 49(4):1133-9. PMID: 11240256.
      View in: PubMed
    161. Manning MA, Cardinale RM, Schmidt-Ullrich RK, Kavanagh BD, Wornom IL, Broaddus WC. Extracorporeal irradiation of tumorous calvaria. Case report. J Neurosurg. 2000 Sep; 93(3):494-7. PMID: 10969952.
      View in: PubMed
    162. Cardinale RM, Kavanagh BD. Conformal radiotherapy: what is it and why does it matter? Surg Oncol Clin N Am. 2000 Jul; 9(3):415-34, vii. PMID: 10853134.
      View in: PubMed
    163. Kavanagh BD, Zwicker RD, Segreti EM, Lindquist LA, Fulcher AS, Hundley GM, Spindler JA, Cardinale RM. Gynecologic brachytherapy: digital fluoroscopy for placement verification and treatment planning. Radiology. 2000 Jun; 215(3):900-3. PMID: 10831719.
      View in: PubMed
    164. Manning MA, Cardinale RM, Benedict SH, Kavanagh BD, Zwicker RD, Amir C, Broaddus WC. Hypofractionated stereotactic radiotherapy as an alternative to radiosurgery for the treatment of patients with brain metastases. Int J Radiat Oncol Biol Phys. 2000 Jun 01; 47(3):603-8. PMID: 10837942.
      View in: PubMed
    165. Kavanagh BD, Campbell RL, Patterson JW, O'Neill RL, Cardinale RM, Kaugars GE. Desmoplastic malignant melanoma of the palatal alveolar mucosa: sustained disease-free survival after surgery and postoperative radiotherapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000 Apr; 89(4):465-70. PMID: 10760728.
      View in: PubMed
    166. Fulcher AS, O'Sullivan SG, Segreti EM, Kavanagh BD. Recurrent cervical carcinoma: typical and atypical manifestations. Radiographics. 1999 Oct; 19 Spec No:S103-16; quiz S264-5. PMID: 10517448.
      View in: PubMed
    167. Cardinale RM, Wu Q, Benedict SH, Kavanagh BD, Bump E, Mohan R. Determining the optimal block margin on the planning target volume for extracranial stereotactic radiotherapy. Int J Radiat Oncol Biol Phys. 1999 Sep 01; 45(2):515-20. PMID: 10487579.
      View in: PubMed
    168. Zwicker RD, Arthur DW, Kavanagh BD, Mohan R, Schmidt-Ullrich RK. Optimization of planar high-dose-rate implants. Int J Radiat Oncol Biol Phys. 1999 Jul 15; 44(5):1171-7. PMID: 10421552.
      View in: PubMed
    169. Wong DT, Gomez M, McGuire GP, Kavanagh B. Utilization of intensive care unit days in a Canadian medical-surgical intensive care unit. Crit Care Med. 1999 Jul; 27(7):1319-24. PMID: 10446826.
      View in: PubMed
    170. Khandelwal SR, Kavanagh BD, Lin PS, Truong QT, Lu J, Abraham DJ, Schmidt-Ullrich RK. RSR13, an allosteric effector of haemoglobin, and carbogen radiosensitize FSAII and SCCVII tumours in C3H mice. Br J Cancer. 1999 Feb; 79(5-6):814-20. PMID: 10070874; PMCID: PMC2362693.
    171. Arthur DW, Kavanagh BD, Schmidt-Ullrich RK. Re: Hsu et al. 1998; 40(2):405-410. Int J Radiat Oncol Biol Phys. 1998 Dec 01; 42(5):1177-8. PMID: 9869248.
      View in: PubMed
    172. Kavanagh BD, Kachnic LA, Amaker BH, Broaddus WC, Cardinale RM, Manning MA, Ginder G, Pizzuti T. A 54-year-old woman with recurrent headaches and seizures. Oncology (Williston Park). 1998 Nov; 12(11):1669-73. PMID: 9834942.
      View in: PubMed
    173. Kavanagh BD, Dent P, Schmidt-Ullrich RK, Chen P, Mikkelsen RB. Calcium-dependent stimulation of mitogen-activated protein kinase activity in A431 cells by low doses of ionizing radiation. Radiat Res. 1998 Jun; 149(6):579-87. PMID: 9611096.
      View in: PubMed
    174. Schmidt-Ullrich RK, Mikkelsen RB, Dent P, Todd DG, Valerie K, Kavanagh BD, Contessa JN, Rorrer WK, Chen PB. Radiation-induced proliferation of the human A431 squamous carcinoma cells is dependent on EGFR tyrosine phosphorylation. Oncogene. 1997 Sep 04; 15(10):1191-7. PMID: 9294612.
      View in: PubMed
    175. Kavanagh BD, Gieschen HL, Schmidt-Ullrich RK, Arthur D, Zwicker R, Kaufman N, Goplerud DR, Segreti EM, West RJ. A pilot study of concomitant boost accelerated superfractionated radiotherapy for stage III cancer of the uterine cervix. Int J Radiat Oncol Biol Phys. 1997 Jun 01; 38(3):561-8. PMID: 9231680.
      View in: PubMed
    176. Lutz ST, Huang DT, Ferguson CL, Kavanagh BD, Tercilla OF, Lu J. A retrospective quality of life analysis using the Lung Cancer Symptom Scale in patients treated with palliative radiotherapy for advanced nonsmall cell lung cancer. Int J Radiat Oncol Biol Phys. 1997 Jan 01; 37(1):117-22. PMID: 9054885.
      View in: PubMed
    177. Kavanagh BD, Lin PS, Chen P, Schmidt-Ullrich RK. Radiation-induced enhanced proliferation of human squamous cancer cells in vitro: a release from inhibition by epidermal growth factor. Clin Cancer Res. 1995 Dec; 1(12):1557-62. PMID: 9815956.
      View in: PubMed
    178. Zwicker RD, Atari NA, Kavanagh BD, Gieschen HL, Arnfield MR, Khandelwal SR, Schmidt-Ullrich RK. Clinical use of a digital simulator for rapid setup verification in high dose rate brachytherapy. Int J Radiat Oncol Biol Phys. 1995 Nov 01; 33(4):931-6. PMID: 7591905.
      View in: PubMed
    179. Arthur D, Kaufman N, Schmidt-Ullrich R, Kavanagh B, Simpson P, Hill M, Ali M. Heuristically derived tumor burden score as a prognostic factor for stage IIIB carcinoma of the cervix. Int J Radiat Oncol Biol Phys. 1995 Feb 15; 31(4):743-51. PMID: 7860385.
      View in: PubMed
    180. Kavanagh BD, Bentel GC, Montana GS. Soft tissue complication rates after low dose rate brachytherapy using customized perineal templates. Int J Radiat Oncol Biol Phys. 1994 Sep 30; 30(2):508. PMID: 7619103.
      View in: PubMed
    181. Mak AC, Rich TA, Schultheiss TE, Kavanagh B, Ota DM, Romsdahl MM. Late complications of postoperative radiation therapy for cancer of the rectum and rectosigmoid. Int J Radiat Oncol Biol Phys. 1994 Feb 01; 28(3):597-603. PMID: 8113102.
      View in: PubMed
    182. Kavanagh BD, Brizel DM, Leopold KA, Acker JC. Radiation therapy for head and neck cancer in a patient with Takayasu's arteritis. Acta Oncol. 1994; 33(1):73-4. PMID: 7908210.
      View in: PubMed
    183. Kavanagh BD, Halperin EC, Nilaver G. Syndrome of inappropriate secretion of antidiuretic hormone in a patient with carcinoma of the nasopharynx. Cancer. 1993 Jul 01; 72(1):299. PMID: 8508422.
      View in: PubMed
    184. Kavanagh BD, Coffey BE, Needham D, Hochmuth RM, Dewhirst MW. The effect of flunarizine on erythrocyte suspension viscosity under conditions of extreme hypoxia, low pH, and lactate treatment. Br J Cancer. 1993 Apr; 67(4):734-41. PMID: 8471430; PMCID: PMC1968366.
    185. Dewhirst MW, Ong ET, Madwed D, Klitzman B, Secomb T, Brizel D, Bonaventura J, Rosner G, Kavanagh B, Edwards J, et al. Effects of the calcium channel blocker flunarizine on the hemodynamics and oxygenation of tumor microvasculature. Radiat Res. 1992 Oct; 132(1):61-8. PMID: 1410275.
      View in: PubMed
    186. Kavanagh BD, Halperin EC, Rosenbaum LC, Shannon EM, Nilaver G. Syndrome of inappropriate secretion of antidiuretic hormone in a patient with carcinoma of the nasopharynx. Cancer. 1992 Mar 15; 69(6):1315-9. PMID: 1540868.
      View in: PubMed
    187. Kavanagh B, Anscher M, Leopold K, Deutsch M, Gaydica E, Dodge R, Allen K, Allen D, Staub W, Montana G, et al. Patterns of failure following combined modality therapy for esophageal cancer, 1984-1990. Int J Radiat Oncol Biol Phys. 1992; 24(4):633-42. PMID: 1429085.
      View in: PubMed
    Kavanagh's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _

    Copyright © 2017 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.10.0)